Daniel Martin
Corporate Officer/Principal at DECIPHERA PHARMACEUTICALS, INC.
Net worth: 867 006 $ as of 2024-03-30
Profile
Daniel C.
Martin is currently the Chief Commercial Officer & Senior Vice President at Deciphera Pharmaceuticals, Inc. Prior to this, he worked as the Vice President-Marketing & Market Access at Heron Therapeutics, Inc. from 2017 to 2018.
Mr. Martin completed his undergraduate degree at the University of Virginia and earned an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-15 | 55,118 ( 0.07% ) | 867 006 $ | 2024-03-30 |
Daniel Martin active positions
| Companies | Position | Start |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2018-09-17 |
Former positions of Daniel Martin
| Companies | Position | End |
|---|---|---|
| HERON THERAPEUTICS, INC. | Sales & Marketing | 2018-08-31 |
Training of Daniel Martin
| University of Virginia | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
- Stock Market
- Insiders
- Daniel Martin
